EXPRESSION PROFILING FOR DETERMINING THE RESPONSIVENESS OF CANCERS TO TREATMENT WITH AN ANTI-ANGIOGENIC AGENT
摘要
<p>The present invention relates to a cancer sub-type. Provided are methods for determining clinical prognosis of a subject with cancer, selecting whether to administer an anti-angiogenic therapeutic agent to a subject with cancer and predicting responsiveness of a subject with cancer to an anti-angiogenic therapeutic agent. The methods are based on assessing from the expression level of biomarkers disclosed herein whether the cancer belongs to the sub- type. Companion methods of treating cancer and agents for use in treating cancer are also provided.</p>